French AFU Cancer Committee Guidelines - Update 2024-2026: Non-muscle invasive bladder cancer (NMIBC).

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Elsevier Masson SAS Country of Publication: France NLM ID: 9918752079106676 Publication Model: Print Cited Medium: Internet ISSN: 2950-3930 (Electronic) Linking ISSN: 29503930 NLM ISO Abbreviation: Fr J Urol Subsets: MEDLINE
    • Publication Information:
      Original Publication: [Paris] : Elsevier Masson SAS, [2024]-
    • Subject Terms:
      Urinary Bladder Neoplasms*/pathology ; Urinary Bladder Neoplasms*/therapy ; Neoplasm Invasiveness*; Humans ; Cystectomy ; Non-Muscle Invasive Bladder Neoplasms
    • Abstract:
      Objective: To update the CCAFU recommendations for the management of non-muscle invasive bladder cancer (NMIBC).
      Methods: A systematic review (Medline) of the literature from 20222024 was performed, taking into account the elements of diagnosis, treatment options and monitoring of NMIBC and evaluating references with their level of evidence.
      Results: The diagnosis of NMIBC (Ta, T1, or CIS) is made after complete and deep tumour resection. The use of bladder photodynamic diagnosis and the indication for a second TURBT (4 to 6weeks later) help to improve the initial diagnosis. The risk of recurrence and/or tumour progression is assessed via the EORTC score. By stratifying patients into low-, intermediate- and high-risk groups, adjuvant treatment can be proposed, including endovesical instillations of chemotherapy (immediate postoperative regimen), BCG (induction and maintenance regimen), or even the indication of cystectomy for unresponsive patients.
      Conclusion: Updating the CCAFU's recommendations should help improve patient management, as well as the diagnosis and treatment of NMIBC.
      (Copyright © 2024. Published by Elsevier Masson SAS.)
    • Contributed Indexing:
      Keywords: Bladder tumours; Cancer; Cystectomy; Survival; Urinary cytology
    • Publication Date:
      Date Created: 20241124 Date Completed: 20241124 Latest Revision: 20241124
    • Publication Date:
      20241126
    • Accession Number:
      10.1016/j.fjurol.2024.102742
    • Accession Number:
      39581667